stockportfolio.pro
Stocks / MDT vs VRTX
MDT vs VRTX
Medtronic plc and Vertex Pharmaceuticals Incorporated side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
| Medtronic plc (MDT) | Vertex Pharmaceuticals Incorporated (VRTX) | |
|---|---|---|
| Market cap | $105.3B | $113.1B |
| Revenue (latest FY) | $36.33B | $12.00B |
| Net income (latest FY) | $4.80B | $3.95B |
| Revenue growth (5y CAGR) | 3.8% | 14.1% |
| Net margin | 13.2% | 32.9% |
| Return on equity | — | 21.2% |
| P/E ratio | 22.0 | 26.5 |
| Dividend yield | 3.6% | — |
| Profitable years (of last 10) | 10 | 8 |
| Positive free cash flow | — | Yes |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open MDT — free Open VRTX — freeFrequently asked questions
Which is bigger, MDT or VRTX?
Vertex Pharmaceuticals Incorporated is larger by market capitalization — $113.1B versus $105.3B.
Which grows faster, MDT or VRTX?
Over the last five fiscal years, Vertex Pharmaceuticals Incorporated grew revenue faster — 14.1%/yr versus 3.8%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.